← Issue №10/ week of Sep 6, 2026/Colorectal

Longitudinal Data from a Large, Multi-Target Stool DNA Colorectal Cancer Screening Program.

From GI Signals issue №10: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal retrospective · n=110,410 · Sep 3, 2026 · Am J Gastro · IF 9.8

Longitudinal Data from a Large, Multi-Target Stool DNA Colorectal Cancer Screening Program.

New evidencecolorectal cancer screeningbiomarkerartificial intelligencehealth services
Clinical takeawayPrioritize colonoscopy follow-up within 6 months after a positive mt-sDNA test to maximize advanced adenoma detection, and address system-level barriers to repeat mt-sDNA testing every 3 years after a negative result, as only 35.3% adhered to repeat testing.
What it foundColonoscopy after positive mt-sDNA had a 30.7% advanced adenoma yield and 1.3% adenocarcinoma yield, exceeding specialty society benchmarks (adenoma detection rate >50%). Longer intervals (>6 months) to colonoscopy were associated with higher advanced adenoma detection (trend P=0.001).
ContextConfirms mt-sDNA as a high-yield screening tool but highlights critical gaps in follow-up (65.1% completion within 12 months) and repeat testing adherence (35.3% within 3 years), which undermine program effectiveness.
Measured against the standard of care· USMSTF 2020 (Gupta et al., post-polypectomy surveillance) / USMSTF 2026 (Rex et al., Serrated Polyposis Syndrome consensus statement)

Decision at stakethe clinical decision to use mt-sDNA as a screening tool for colorectal cancer

No single passage of this standard matched the paper closely enough to quote, so none is shown. The standard is cited above.

Our full summary of this standard

General post-polypectomy surveillance still follows USMSTF 2020 (Gupta et al.), which has not been replaced: 1-2 tubular adenomas <10 mm, 7-10 years; 3-4 tubular adenomas <10 mm, 3-5 years; 5-10 tubular adenomas <10 mm, any adenoma ≥10 mm, or an adenoma with tubulovillous/villous histology or high-grade dysplasia, 3 years; >10 adenomas, 1 year with polyposis evaluation. For serrated polyps: 1-2 SSLs <10 mm, 5-10 years; 3-4 SSLs <10 mm or a hyperplastic polyp ≥10 mm, 3-5 years; an SSL ≥10 mm, an SSL with dysplasia, or a traditional serrated adenoma, 3 years. When findings are mixed, use the shortest interval indicated. Before applying an interval, confirm complete resection and adequate prep. Piecemeal resections get a site check, and malignant (T1) polyps go to a tumor-board pathway. Serrated polyposis syndrome (SPS) is now governed by a separate USMSTF consensus statement (Rex et al., published simultaneously in Gastroenterology, Am J Gastroenterol and GIE on 2026-09-30). It has 11 recommendations. Diagnose SPS with the 2019 WHO criteria, which count the size, cumulative lifetime number and location of serrated polyps. Until SPS is diagnosed, record the number, size and location of serrated polyps in every colonoscopy report. SPS colonoscopy should be done by endoscopists with documented adequate SSL detection, using high-definition white light with or without chromoendoscopy. Without concurrent CRC, endoscopy is preferred over surgery for primary management. If the polyp burden cannot be managed endoscopically, refer to an advanced endoscopic resection expert before surgery. Resect SSLs and hyperplastic polyps by cold snare, with submucosal injection for larger lesions. Do clearance colonoscopy at 3-6 months, then surveil every 1-2 years. Consider 3-year intervals if the burden is greatly reduced at surveillance. First-degree relatives start colonoscopy at age 40, or 10 years before the youngest CRC diagnosis in the family, or 5 years before the youngest SPS diagnosis, whichever comes first. SPS has no established genetic basis, so germline testing is recommended only when concurrent non-serrated polyps suggest a heritable syndrome. Lynch, FAP/AFAP and MAP criteria still trigger genetic evaluation.

USMSTF 2020 (Gupta et al., post-polypectomy surveillance) / USMSTF 2026 (Rex et al., Serrated Polyposis Syndrome consensus statement) · reviewed 2026-10-11 ↗
Garg SK … Chaudhary R · American Journal of Gastroenterology · IF 9.8 · PubMed ↗Permalink
← Read the whole of issue №10 Every paper GI Signals surfaces gets a page like this one. All issues